This review is an update of an earlier narrative review published in 2015 on developments
in the clinical management of cutaneous leishmaniasis (CL) including diagnosis, treatment …

Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania.
It is a global disease, but most cases are seen in South America, the Mediterranean, and …

Cutaneous leishmaniasis (CL) is called “the great imitator,” because it can mimic almost all
types of dermatoses. This similarity may sometimes lead to misdiagnosis, resulting in …

Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania.
It is a global disease, but most cases are seen in South America, the Mediterranean, and …

Background Leishmaniasis, a disease caused by a protozoan, causes numerous deaths in
humans each year. After malaria, leishmaniasis is known to be the deadliest parasitic …

Endemic in 149 tropical and subtropical countries, neglected tropical diseases (NTDs) affect
more than 1 billion people annually with over 500,000 deaths. Among the NTDs, some of the …

Leishmaniasis is a vector-borne infectious disease with a long history of infecting humans
and other animals. It is a known emerging or resurging disease. The host nutritional state …

Leishmaniasis is a relevant disease worldwide due to its presence in many countries and an
estimated prevalence of 10 million people. The causative agent of this disease is the …

Background: Iran is among the first six countries in the world with the highest annual
incidence of cutaneous leishmaniasis. This study aimed at estimating the incidence, burden …

Leishmania (Viannia) braziliensis is an important Leishmania species circulating in several
Central and South American countries. Among Leishmania species circulating in Brazil …